Arkema S.A. (OTCMKTS:ARKAY – Get Free Report) was the recipient of a large decline in short interest during the month of September. As of September 30th, there was short interest totalling 3,700 shares, a decline of 24.5% from the September 15th total of 4,900 shares. Based on an average trading volume of 7,100 shares, the days-to-cover ratio is currently 0.5 days.
Arkema Price Performance
Shares of Arkema stock opened at $94.78 on Monday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.38 and a current ratio of 1.86. Arkema has a 52-week low of $84.55 and a 52-week high of $114.15. The company has a fifty day moving average of $90.57 and a 200-day moving average of $95.59. The stock has a market capitalization of $7.11 billion, a price-to-earnings ratio of 18.73, a price-to-earnings-growth ratio of 0.42 and a beta of 1.27.
Arkema (OTCMKTS:ARKAY – Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The basic materials company reported $2.98 earnings per share (EPS) for the quarter. The business had revenue of $2.73 billion during the quarter. Arkema had a net margin of 3.80% and a return on equity of 8.18%. Equities research analysts expect that Arkema will post 9.09 EPS for the current year.
Arkema Company Profile
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Featured Articles
- Five stocks we like better than Arkema
- Investing In Automotive Stocks
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- How to Use the MarketBeat Stock Screener
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.